Active Stocks
Mon Feb 10 2025 13:12:54
  1. Tata Steel share price
  2. 133.85 -3.22%
  1. State Bank Of India share price
  2. 738.05 0.14%
  1. Reliance Industries share price
  2. 1,248.55 -1.44%
  1. Tata Motors share price
  2. 695.65 -1.54%
  1. ITC share price
  2. 427.60 -0.77%
Business News/Market/Market Stats/    Tata India Pharma & Healthcare Fund Regular Growth

Tata India Pharma & Healthcare Fund Regular Growth

+
  • Equity
  • Sector - Healthcare
  • Rating N.A.
  • Plan
30.00 -0.15 (-0.50%) NAV as on 07 Feb, 2025
  • 5D
  • 1M
  • 6M
  • 1Y
  • 5Y
  • MAX

Key Metrics

  • AUM (in Cr)1287.45
  • CAGR 23.45%
  • Exit Load0.25%
  • Expense ratio2.14%
  • CategoryEquity
  • Min Investment5000
  • Min SIP100
  • Launch Date2015-12-28

Morning Star Rating N.A.

Medium
Risk
Exceptional
Return

Asset Allocation

Holdings As On - 10 February 2025

  • Name
  • Value (Cr)
  • Holding %
  • Cash / Net Current Asset
  • 61.20
  • 4.75%
View More

Risk & Volitility

  • Alpha 11.23%
  • Beta 0.70
  • Sharpe Ratio0.93
  • Std Deviation 15.20%
  • Tracking Error 10.07%

About Fund

The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.

 

The Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1287.45 crores & has delivered CAGR of 25.44% in the last 5 years. The fund has an exit load of 0.25% and an expense ratio of 2.14%. The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is Rs 5000 and the minimum SIP is Rs 100.

 

As per morningstar the risk & return rating of the fund are Medium & Exceptional respectively.

 

The top holdings of the fund include Sun Pharmaceutical Industries, Aurobindo Pharma, Lupin & Dr Reddys Laboratories.

 

The major sectors where the fund is invested are Biotechnology & Drugs, Healthcare Facilities, Major Drugs & Chemical Manufacturing.

 

Some of the similar funds are Tata India Pharma & Healthcare Fund Regular Growth, UTI Healthcare Fund Regular Plan Growth, Mirae Asset Healthcare Fund Regular Growth, Aditya Birla Sun Life Pharma & Healthcare Fund Regular Growth, HDFC Pharma and Healthcare Fund Regular Growth. Tata India Pharma & Healthcare Fund Regular Growth has a sharpe ratio of 0.93 & a standard deviation of 15.20%.

FAQs about Tata India Pharma & Healthcare Fund Regular Growth

According to the morning star rating Tata India Pharma & Healthcare Fund Regular Growth has a Medium risk & Exceptional return.
Tata India Pharma & Healthcare Fund Regular Growth is managed by Meeta Shetty,Rajat Srivastava.
The expense ratio of Tata India Pharma & Healthcare Fund Regular Growth is 2.14%.
The 5 year annualized return on Tata India Pharma & Healthcare Fund Regular Growth is 25.44% & it has generated 23.45% in the last 1 year.
The minimum investment in Tata India Pharma & Healthcare Fund Regular Growth is 5000 Rs.
Tata India Pharma & Healthcare Fund Regular Growth has an AUM of 1287.45 crores.
Recommended For You